Latest Malaysia News

ReNerve’s October AGM presentation points to sharply higher sales, a growing US distribution network and a broader nerve repair pipeline. The company is also progressing a 240-patient NervAlign clinical study while relying on a $5 million RiverFort funding facility to support expansion.

Unity Metals has opened a non-renounceable share purchase plan targeting $1 million to fund gold and copper-gold exploration in Cambodia and Thailand. Eligible shareholders can buy shares at a 15.2% discount, with attaching options subject to a later shareholder vote.

Xamble has appointed Adrian Tan permanent CEO and elevated Georg Johann Chmiel to chair as it seeks to convert recent operating improvements into sustained growth. Ganesh Kumar Bangah is stepping down from the board to take a senior Malaysian government-linked role but will remain involved as an adviser and substantial shareholder.

Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.

Novatti has reported a statutory profit and positive EBITDA for FY26 after cutting low-margin revenue and concentrating on Payments AU/NZ. The turnaround is substantial, but an auditor-flagged going-concern uncertainty, upcoming debt maturities and negative operating cash flow leave the recovery unfinished.

Besra Gold’s FY2026 report puts its Gold Purchase Agreement with major shareholder Quantum Metal Recovery at the centre of the company’s financial risk profile. Funding received under the deal has been recorded as a contract liability tied to potential future gold deliveries, while the report also discloses an AU$140,000 payment to a former director.

Brazilian Critical Minerals has reported striking economics for its Ema rare earths project, including a US$1.47 billion post-tax NPV, 105% IRR and six-month payback. The company’s A$7.87 million FY2026 loss, December debt maturity, permitting requirements and unresolved Drake dispute leave the development case dependent on execution and further funding.

Me Today reported a NZ$2.66 million FY26 profit, but the result was dominated by a NZ$4.12 million gain from losing control of King Honey. The remaining business grew revenue and improved its operating loss, yet continued to consume cash and will rely on October warrant funding.

Ovanti’s Malaysian subsidiary iSentric has secured a RM5.17 million High Court judgment, worth about A$1.78 million, against two companies tied to historical transactions. The company is also preparing further claims against former directors, officers and auditors, with estimated outstanding claims of up to A$20 million, although no recovery is guaranteed.

ReNerve has converted regulatory approvals into its first commercial NervAlign Nerve Cuff surgeries in Hong Kong and Malaysia, expanding activity to seven jurisdictions. The milestones arrive as FY26 sales climbed 88% to $510,357 and the company builds out its US distribution network.

Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.

Codan Limited (ASX:CDA) has entered FY27 with record revenue, profit and a sharply larger Communications orderbook, while targeting approximately 20% Communications revenue growth. The forecast is conditional on supply-chain capacity as demand for unmanned systems and new gold detectors accelerates.